In conclusion, this study demonstrated increased IL-12p40 and CSF-1 concentrations in CFS/ME patients in addition to a set of predictive biomarkers. This evidence concerns the gene CSF1 and myalgic encephalomeyelitis/chronic fatigue syndrome.